Navigation Links
Nventa Announces Presentation of Positive HspE7 Data from,NCI-Sponsored Clinical Trial in Cervical Dysplasia

DA before products can be tested in clinical trials; the possibility that such government agency approvals will not be obtained in a timely manner or at all or will be conditioned in a manner that would impair our ability to advance development; risks associated with the requirement that a drug be found safe and effective after extensive clinical trials and the possibility that the results of such trials, if commenced and completed, will not establish the safety or efficacy of our products; our dependence on suppliers, collaborative partners and other third parties and the prospects and timing for negotiating supply agreements, corporate collaborations or licensing arrangements; our ability to attract and retain key personnel; our ability to protect and practice our intellectual property; and other factors as described in detail in our filings with the Canadian securities regulatory authorities at www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement.

Assumptions underlying our expectations regarding forward-looking statements or information contained in this press release include, among others, that we will raise enough capital, on reasonable terms and in a timely manner; that we will retain our key personnel; that we will obtain the necessary regulatory approvals related to HspE7 and our adjuvant in a timely manner; that enough HspE7 will be available to conduct out planned trials; that we will be able to procure the necessary amount of adjuvant to conduct our planned trials; that we will obtain timely approval from IRB; that the results from additional preclinical work, if any, will be consistent with the results we have already obtained; and that a sufficient number of patients will be available to conduct our planned trials; and that sufficien
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/2/2015)... Sept. 2, 2015 Research and Markets ... the "An Introduction to Medical Device Software: ... 2015)" conference to their offering. ... to the regulations and requirements that apply to ... interactive, using real life examples and state-of- the-art ...
(Date:9/2/2015)...  Research and Markets ( http://www.researchandmarkets.com/research/rf2c5p/an_introduction ) has ... to the Medical Devices Directive (London, UK - ... This seminar provides a detailed ... will explain the Directives and which products are ... choose one and outline what a manufacturer must ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
(Date:9/3/2015)... ... September 03, 2015 , ... Global Vision , the world ... be spotlighting its award-winning print and artwork inspection solutions, ScanProof and ArtProof ... 17 at the Olympia London, booth #F33 , Be the first to get a ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... data collection, cloud analytics and workflow solutions today announced the complete faculty ... September 22-24, 2015. The esteemed faculty of worldwide pharmaceutical and industry experts ...
(Date:9/3/2015)... ... September 03, 2015 , ... “Love in Tokyo” an ... Google Play , and Amazon and will be released on DVD early ... Darling is a Foreigner,” Itsuka, an actress and singer/songwriter, and Jason London, lead from ...
(Date:9/3/2015)... ... ... types of people who have a hard time gaining weight , it seems that ... those that have a fast metabolism. In order to help those people who have a ... slowing down metabolism. , The first thing to do is to space out meals. When ...
(Date:9/3/2015)... ... September 03, 2015 , ... Doctor Kayode Sotonwa can be counted on ... His perspective on internal medicine keeps patients happy and healthy, something that is important ... of the season, but even more so in the fall, when holiday eating and ...
Breaking Medicine News(10 mins):Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 2Health News:Global Vision to Spotlight Intelligent Proofreading at Packaging Innovations 2015 3Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 2Health News:ERT Announces Final Agenda, Faculty for European PRO / eCOA Congress 3Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 2Health News:CB-1 Weight Gainer Gives Three Tips for Slowing Down Metabolism 3Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... Access to Basic,Care plan could help thousands of ... of Community and Economic Development,Secretary Dennis Yablonsky said ... "The vast majority of Pennsylvania,s uninsured adults ... businesses that struggle to make a,profit," said Yablonsky. ...
... D,ALENE, Idaho, May 23 NightHawk,Radiology Holdings, Inc. ... radiology,solutions to radiology groups and hospitals throughout the ... the Goldman Sachs 29th Annual,Global Healthcare Conference in ... at,8:40 am PDT. Presenting at the conference will ...
... also lower cholesterol, study says , , FRIDAY, May ... in antioxidants and may help protect against liver damage, ... The berries of the plant -- indigenous to the ... well known for their high levels of antioxidants and ...
... Linkwell,Corporation (Linkwell) (OTC Bulletin Board: LWLL), a ... disinfectants in China,announced today that it was ... relief efforts. The Chinese government, non-government,organizations (NGOs) ... scale in response to the earthquake in ...
... John G. Rangos Sr. Research Center at Childrens Hospital ... for the development of new therapies to treat hypertriglyceridemia, ... obese and diabetic. Results of their study are published ... Investigation. , Scientists in the Division of Immunogenetics at ...
... make a world of difference for Singer Songwriter Katie ... Reider Beginning May 23, ... songwriter Katie Reider, age 29, has inspired the hearts of,thousands with ... across the country are banding together to help Katie,during her ongoing ...
Cached Medicine News:Health News:PA ABC Will Benefit Commonwealth's Small Businesses, DCED Secretary Says 2Health News:NightHawk Radiology Holdings, Inc. to Speak at the Goldman Sachs 29th Annual Global Healthcare Conference 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 2Health News:Linkwell Corporation Runs 24/7 Disinfectant Operations to Support China's Earthquake Relief Efforts 3Health News:Pittsburgh scientists find protein may be key to new therapies for elevated triglycerides 2Health News:Katie Reider - Listen to Her Songs, Hear Her Story, Log Onto www.500kin365.org 2Health News:Katie Reider - Listen to Her Songs, Hear Her Story, Log Onto www.500kin365.org 3
... tray is specifically designed for a variety ... x 13.34cm dot blot transfer membranes. The ... a standard microplate for compatibility with various ... available dot blot membranes without trimming., With ...
Mini Trans-Blot and PowerPac 300 System, 110-120 V...
... The GENIE is the proven electrophoretic transfer apparatus ... field uniformity. Its design allows for a very ... with a low voltage power source such as ... volts/cm. The result is exceptionally rapid and exact ...
... transfer apparatus incorporating state-of-the-art plate electrodes for the ... a very close positioning of the electrodes which, ... such as a battery charger, creates a high ... and exact electrophoretic transfer. ...
Medicine Products: